Neurofibromatosis type 2 discordance in monozygous twins

被引:2
|
作者
Amico, S. [1 ]
Smith, P. [1 ]
Tobi, S. [1 ]
Perry, M. [1 ]
Wallace, A. [1 ]
Evans, D. G. [1 ]
机构
[1] Univ Manchester, Manchester Univ Hosp Fdn Trust, MAHSC,St Marys Hosp, Dept Genom Med,Div Evolut & Genom Sci, Manchester, England
关键词
Neurofibromatosis; 2; Genetic testing; Twins monozygotic; Cancer genetics; MOSAICISM; CONCORDANT;
D O I
10.1007/s10689-019-00148-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neurofibromatosis type 2 (NF2) is an autosomal dominant condition caused by pathogenic variants in the NF2 gene. The pathogenic variant is either inherited or obtained by de novo mutation, characterised by the presence of schwannomas, meningiomas and ependymomas. Here we report the presence of NF2 in one twin, with bilateral vestibular schwannomas and a pathogenic variant of the NF2 gene identified in both tumour and lymphocytes, while his monozygous brother remains asymptomatic. Imaging of the unaffected twin showed no tumour load and genetic testing via Sanger sequencing and Amplification Refractory Mutation System assay demonstrated low levels of expression of the NF2 variant in lymphocytes. Further testing on non-haemopoietic tissue showed little expression or absence of the pathogenic variant. Given there is no family history and the low level of the variant, we assume the pathogenic variant is a de novo mutation during embryogenesis. De novo mutations have been described as occurring at three possible time points in the creation of monozygous twins with different genetic make-up; prior to the twinning event, as a cause of the event, or after the twinning event. Of these options, we hypothesise that the discordance in the expression of the NF2 variant between these twins is likely due to a mutational event that occurred as a result of either of the latter two possibilities, between which we cannot determine. The pathogenic variant in lymphocytes was likely transferred between the twins through a shared blood supply in utero, and the non-haemopoietic samples that showed low levels of expression, were likely due to the presence of lymphocytic cells. Therefore, we have a discordance between monozygous twins at the NF2 gene.
引用
收藏
页码:37 / 40
页数:4
相关论文
共 50 条
  • [1] Neurofibromatosis type 2 discordance in monozygous twins
    S. Amico
    P. Smith
    S. Tobi
    M. Perry
    A. Wallace
    D. G. Evans
    Familial Cancer, 2020, 19 : 37 - 40
  • [2] Phenotypic variability in monozygotic twins with neurofibromatosis 2
    Baser, ME
    Ragge, NK
    Riccardi, VM
    Janus, T
    Gantz, B
    Pulst, SM
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1996, 64 (04): : 563 - 567
  • [3] Analysis of Copy Number Variants in 11 Pairs of Monozygotic Twins with Neurofibromatosis Type
    Sites, Emily R.
    Smolarek, Teresa A.
    Martin, Lisa J.
    Viskochil, David H.
    Stevenson, David A.
    Ullrich, Nicole J.
    Messiaen, Ludwine M.
    Schorry, Elizabeth K.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2017, 173 (03) : 647 - 653
  • [4] Monozygotic Twins Discordant for Neurofibromatosis 1
    Kaplan, Lee
    Foster, Rosemary
    Shen, Yiping
    Parry, Dilys M.
    McMaster, Mary L.
    O'Leary, Melanie Collins
    Gusella, James F.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2010, 152A (03) : 601 - 606
  • [5] A comparison of neuropsychological function between monozygotic twins with neurofibromatosis, type 1: A case report
    Pendergrass, Cody
    Peraza, Jennifer
    CLINICAL NEUROPSYCHOLOGIST, 2020, 34 (05) : 1049 - 1064
  • [6] Management strategies in neurofibromatosis type 2
    Moffat, DA
    Quaranta, N
    Baguley, DM
    Hardy, DG
    Chang, P
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2003, 260 (01) : 12 - 18
  • [7] Psychiatric symptoms in neurofibromatosis type 2
    Khouadja, S.
    Melki, R.
    Younes, S.
    Zarrouk, L.
    EUROPEAN PSYCHIATRY, 2021, 64 : S238 - S238
  • [8] Variable Expression of Neurofibromatosis 1 in Monozygotic Twins
    Rieley, Margaret B.
    Stevenson, David A.
    Viskochil, David H.
    Tinkle, Brad T.
    Martin, Lisa J.
    Schorry, Elizabeth K.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2011, 155A (03) : 478 - 485
  • [9] 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis
    Fisher, Michael J.
    Belzberg, Allan J.
    de Blank, Peter
    De Raedt, Thomas
    Elefteriou, Florent
    Ferner, Rosalie E.
    Giovannini, Marco
    Harris, Gordon J.
    Kalamarides, Michel
    Karajannis, Matthias A.
    Kim, AeRang
    Lazaro, Conxi
    Le, Lu Q.
    Li, Wei
    Listernick, Robert
    Martin, Staci
    Morrison, Helen
    Pasmant, Eric
    Ratner, Nancy
    Schorry, Elisabeth
    Ullrich, Nicole J.
    Viskochil, David
    Weiss, Brian
    Widemann, Brigitte C.
    Zhu, Yuan
    Bakker, Annette
    Serra, Eduard
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2018, 176 (05) : 1258 - 1269
  • [10] MASS IN THE BACK AS MANIFESTATION OF NEUROFIBROMATOSIS TYPE 2
    van den Hauwe, A. S. Michel L.
    Degryse, H.
    JBR-BTR, 2010, 93 (03): : 144 - 145